307 related articles for article (PubMed ID: 17717078)
1. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor transactivation of the secretory leukocyte protease inhibitor gene in Ishikawa endometrial epithelial cells involves recruitment of Krüppel-like factor 9/basic transcription element binding protein-1.
Velarde MC; Iruthayanathan M; Eason RR; Zhang D; Simmen FA; Simmen RC
Endocrinology; 2006 Apr; 147(4):1969-78. PubMed ID: 16384861
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor co-regulator Krüppel-like factor 9 and prohibitin 2 expression in estrogen-induced epithelial cell proliferation in the mouse uterus.
Pabona JM; Velarde MC; Zeng Z; Simmen FA; Simmen RC
J Endocrinol; 2009 Jan; 200(1):63-73. PubMed ID: 18835980
[TBL] [Abstract][Full Text] [Related]
5. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S
Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449
[TBL] [Abstract][Full Text] [Related]
6. Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells.
Zhang XL; Zhang D; Michel FJ; Blum JL; Simmen FA; Simmen RC
J Biol Chem; 2003 Jun; 278(24):21474-82. PubMed ID: 12672823
[TBL] [Abstract][Full Text] [Related]
7. Ligand activated hPR modulates the glycodelin promoter activity through the Sp1 sites in human endometrial adenocarcinoma cells.
Gao J; Mazella J; Seppala M; Tseng L
Mol Cell Endocrinol; 2001 May; 176(1-2):97-102. PubMed ID: 11369448
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
[TBL] [Abstract][Full Text] [Related]
9. GC-rich promoter elements maximally confers estrogen-induced transactivation of LRP16 gene through ERalpha/Sp1 interaction in MCF-7 cells.
Han WD; Si YL; Zhao YL; Li Q; Wu ZQ; Hao HJ; Song HJ
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):47-56. PubMed ID: 18206366
[TBL] [Abstract][Full Text] [Related]
10. Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3',5'-monophosphate but not estradiol.
Clemens JW; Robker RL; Kraus WL; Katzenellenbogen BS; Richards JS
Mol Endocrinol; 1998 Aug; 12(8):1201-14. PubMed ID: 9717846
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites.
Petz LN; Ziegler YS; Schultz JR; Kim H; Kemper JK; Nardulli AM
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):113-22. PubMed ID: 15084343
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
[TBL] [Abstract][Full Text] [Related]
13. The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells.
Bryant W; Snowhite AE; Rice LW; Shupnik MA
Endocrinology; 2005 Feb; 146(2):751-9. PubMed ID: 15528307
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
16. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
18. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.
Shatnawi A; Tran T; Ratnam M
Mol Endocrinol; 2007 Mar; 21(3):635-50. PubMed ID: 17192405
[TBL] [Abstract][Full Text] [Related]
19. Estrogen regulates KiSS1 gene expression through estrogen receptor alpha and SP protein complexes.
Li D; Mitchell D; Luo J; Yi Z; Cho SG; Guo J; Li X; Ning G; Wu X; Liu M
Endocrinology; 2007 Oct; 148(10):4821-8. PubMed ID: 17656465
[TBL] [Abstract][Full Text] [Related]
20. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]